Kendler, D. L.
Body, J. J.
Brandi, M. L.
Broady, R.
Cannata-Andia, J.
Cannata-Ortiz, M. J.
El Maghraoui, A.
Guglielmi, G.
Hadji, P.
Pierroz, D. D.
de Villiers, T. J.
Rizzoli, R.
Ebeling, P. R.
,
Article History
Received: 18 January 2018
Accepted: 13 August 2018
First Online: 3 September 2018
Compliance with ethical standards
:
: P Hadji received honoraria, travel grants, and scientific research grants from Amgen, Eli Lilly, MSD, Novartis, Pfizer, Procter & Gamble, and Roche. D Kendler received honoraria, speakers bureau, and/or research grants from Amgen, Eli Lilly, MSD, Pfizer, Astrazenica, and Astellas. T de Villiers has acted as a consultant or speaker for the following companies: Abbott, Amgen, Aspen, MSD, Pfizer. R Rizzoli received fees for consultancy or lectures from Danone, EffRx, Nestlé, ObsEva, and Radius Health. PR Ebeling received research grants, honoraria, and/or speakers’ fees from Amgen, Eli Lilly, Novartis, and Gilead. J Cannata-Andia received honoraria and scientific research grants from Amgen, Shire, and VIFOR/Fresenius. JJ Body, ML Brandi, MJ Cannata-Ortiz, A El Magrahoui, G Guglielmi, and DD Pierroz have no conflict of interest to declare.